| abstract |
The present invention is directed to cinolin compounds of the formula (1) which are PDE10 inhibitors, pharmaceutical compositions containing such compounds and process for preparing such compounds. This invention is also directed to methods for treating diseases treatable by the inhibition of PDE10 enzyme, such as obesity, insulin-free diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like. |